Glucocorticoid receptor agonist-1

Name: Glucocorticoid receptor agonist-1
Brand: MedChemExpress
SKU: HY-131974
Rating: 4.5 (1 reviews)

Cat. No.: HY-131974 Purity: 99.80%: FAQs
Data Sheet SDS COA Handling Instructions

Molarity Calculator

Glucocorticoid receptor agonist-1 is a potent glucocorticoid receptor agonist with an IC₅₀ of 2.8 nM extracted from patent WO2017210471A1, compound 41.

For research use only. We do not sell to patients.

Glucocorticoid receptor agonist-1 Chemical Structure

CAS No. : 2166375-82-0

Size	Price	Stock	Quantity
5 mg	USD 680	In-stock	Estimated Time of Arrival: December 31
10 mg	USD 1100	In-stock	Estimated Time of Arrival: December 31
50 mg	USD 3850	In-stock	Estimated Time of Arrival: December 31
100 mg	USD 6160	In-stock	Estimated Time of Arrival: December 31
200 mg		Get quote
500 mg		Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

View All ADC Cytotoxin Isoform Specific Products:

View All Isoforms

Auristatin Calicheamicins Camptothecins Daunorubicins/Doxorubicins Duocarmycins Maytansinoids Pyrrolobenzodiazepines Traditional Cytotoxic Agents

Biological Activity
Purity & Documentation
References
Customer Review

Description

Glucocorticoid receptor agonist-1 is a potent glucocorticoid receptor agonist with an IC₅₀ of 2.8 nM extracted from patent WO2017210471A1, compound 41^[1].

IC₅₀ & Target

IC50: 2.8 nM (Glucocorticoid receptor)^[1]

In Vitro

Glucocorticoid receptor agonist immunoconjugates are useful for treating autoimmune diseases such as, but not limited to, rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn's disease, pediatric Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, uveitis, Behcets disease, a spondyloarthropathy, or psoriasis^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Molecular Weight

569.69

Formula

C₃₅H₃₉NO₆

CAS No.

2166375-82-0

Appearance

Solid

Color

White to off-white

SMILES

OCC([C@]12[C@@]3([C@@]([C@@]4([H])[C@]([C@@]5(C(CC4)=CC(C=C5)=O)C)([H])[C@H](C3)O)([H])C[C@@]1([H])O[C@](C6=CC=C(C=C6)CC7=CC(N)=CC=C7)([H])O2)C)=O

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

Solvent & Solubility

In Vitro:

DMSO : 100 mg/mL (175.53 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	1.7553 mL	8.7767 mL	17.5534 mL
5 mM	0.3511 mL	1.7553 mL	3.5107 mL
10 mM	0.1755 mL	0.8777 mL	1.7553 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 90% Corn Oil
Solubility: ≥ 2.5 mg/mL (4.39 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

DMSO +

Tween-80 +

Saline

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Calculation results:

Working solution concentration: mg/mL

Method for preparing stock solution: mg drug dissolved in μL DMSO (Stock solution concentration: mg/mL).

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).

Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.

If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.

Purity & Documentation

Purity: 99.80%

Select Batch:

Data Sheet (274 KB) SDS (251 KB)

COA (251 KB) HNMR (273 KB) RP-HPLC (239 KB) LCMS (102 KB)

Handling Instructions (2659 KB)

References

[1]. Michael J. Mcpherson, et al. Glucocorticoid receptor agonist and immunoconjugates thereof. WO2017210471A1.

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	1.7553 mL	8.7767 mL	17.5534 mL	43.8835 mL
	5 mM	0.3511 mL	1.7553 mL	3.5107 mL	8.7767 mL
	10 mM	0.1755 mL	0.8777 mL	1.7553 mL	4.3884 mL
	15 mM	0.1170 mL	0.5851 mL	1.1702 mL	2.9256 mL
	20 mM	0.0878 mL	0.4388 mL	0.8777 mL	2.1942 mL
	25 mM	0.0702 mL	0.3511 mL	0.7021 mL	1.7553 mL
	30 mM	0.0585 mL	0.2926 mL	0.5851 mL	1.4628 mL
	40 mM	0.0439 mL	0.2194 mL	0.4388 mL	1.0971 mL
	50 mM	0.0351 mL	0.1755 mL	0.3511 mL	0.8777 mL
	60 mM	0.0293 mL	0.1463 mL	0.2926 mL	0.7314 mL
	80 mM	0.0219 mL	0.1097 mL	0.2194 mL	0.5485 mL
	100 mM	0.0176 mL	0.0878 mL	0.1755 mL	0.4388 mL